Trial Watch: Adoptive cell transfer for anticancer immunotherapy

Mostrar otras versiones (1)

Adoptive cell transfer (ACT) represents a prominent form of immunotherapy against malignant diseases. ACT is conceptually distinct from dendritic cell-based approaches (which de facto constitute cellular vaccines) and allogeneic transplantation (which can be employed for the therapy of hematopoietic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacchelli, Erika, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jérôme, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667909/
https://www.ncbi.nlm.nih.gov/pubmed/23762803
http://dx.doi.org/10.4161/onci.24238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667909/
https://www.ncbi.nlm.nih.gov/pubmed/23762803
http://dx.doi.org/10.4161/onci.24238

Ejemplares similares